METAvivor submitted a formal response to OMB-2026-0034 opposing proposed changes to federal research funding.
METAvivor submitted a formal response to the Office of Management and Budget regarding the proposed Uniform Guidance revisions (OMB-2026-0034), urging the rejection of changes that would undermine merit-based scientific research and federal research funding.
For people living with metastatic breast cancer, strong and stable federal investment in biomedical research is critical to advancing new treatments and improving outcomes. Our response emphasized the importance of preserving an evidence-driven, merit-based review process that is focused on scientific innovation and protects the integrity of federally funded research. Click the button below to read the full response letter.